Found 7 matching trials
Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND) PHASE3 Evaluate the safety and efficacy of Siponimod (BAF312) versus placebo in a ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients PHASE3 To assess safety and tolerability of patients converting from approved Rela...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Safety and Efficacy of BAF312 in Dermatomyositis PHASE2 This study investigated the dose response relationship for the efficacy and...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy, Safety and Tolerability of BAF312 Compared to Placebo in Patients With Intracerebral Hemorrhage (ICH). PHASE2 This is a randomized, placebo-controlled, subject and investigator-blinded ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis PHASE2 This study consisted of a two year dose blinded phase during which patients...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis PHASE3 Efficacy and safety of ofatumumab and siponimod compared to fingolimod in p...
Show More Status
Active Not Recruiting
Location
Arkansas Childrens Hosp Rsch Inst
Learn More & Join Trial
Efficacy and Tolerability of BAF312 in Patients With Polymyositis PHASE2 This study assessed the efficacy, safety and tolerability of BAF312 adminis...
Show More Location
Novartis Investigative Site
Learn More & Join Trial